Weiss Ratings Reiterates Sell (D) Rating for Forian (NASDAQ:FORA)

Forian (NASDAQ:FORA)‘s stock had its “sell (d)” rating reaffirmed by equities research analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

Forian Stock Up 3.2%

NASDAQ:FORA opened at $2.27 on Wednesday. Forian has a 52 week low of $1.64 and a 52 week high of $4.03. The company has a market capitalization of $70.62 million, a P/E ratio of -25.22 and a beta of 1.03. The stock’s fifty day moving average is $2.09 and its two-hundred day moving average is $2.04.

About Forian

Forian Inc provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the healthcare and related industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions.